Bills · S 1702
IN COMMITTEE· 119TH CONGRESS
Senate BillS 1702Health
Access to Prescription Digital Therapeutics Act of 2025
INTRO MAY 8· LAST ACTION MAY 8
READING
5MIN
COSPONSORS
4BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because it could significantly expand access to innovative healthcare technologies for millions of Americans. Currently, many advanced digital health tools that require a doctor's prescription are not consistently covered by government health plans, creating a barrier for patients who could benefit from them. By adding prescription digital therapeutics (PDTs) to Medicare and Medicaid coverage, the bill could make these treatments more affordable and accessible, potentially improving health outcomes for various conditions.
If this bill becomes law, it could accelerate the adoption of digital health solutions in mainstream medicine, encouraging further innovation in the field. However, it also means new costs for taxpayers through Medicare and Medicaid, and the government would need to develop robust systems for evaluating, coding, and paying for these new technologies. If the bill does not pass, access to these FDA-approved digital treatments for Medicare and Medicaid beneficiaries will likely remain inconsistent and depend on individual patient's ability to pay or varied state-level coverage decisions, potentially widening the gap in healthcare access between those with private insurance and those relying on public programs.
KEY PROVISIONS
5AI-extractedPROVISION 01
Adds prescription digital therapeutics (PDTs) as a covered 'medical and other health service' under Medicare Part B.
This makes FDA-approved, software-based health treatments available and financially accessible to over 60 million Medicare beneficiaries.
PROVISION 02
Requires the Secretary of Health and Human Services to establish a payment methodology for PDTs under Medicare within one year of the bill's enactment.
This creates the financial mechanism for how digital health companies will be paid for their products and ensures a consistent payment system.
PROVISION 03
Mandates the creation of specific billing codes (HCPCS codes) for PDTs within two years, with temporary codes in the interim.
Standardized codes are essential for healthcare providers to properly bill for and track the use of these new digital treatments.
PROVISION 04
Requires manufacturers of covered PDTs to submit annual reports on payment rates from private insurers, sales volume, and user numbers, with penalties for non-compliance.
This provision aims to provide transparency on pricing and utilization data, which can inform future payment decisions and policy.
PROVISION 05
Includes prescription digital therapeutics (PDTs) as a covered service under state Medicaid programs.
This extends access to these digital health treatments to millions of low-income individuals and families covered by Medicaid.
SPONSORSHIP
1 + 4
R· West Virginia
YRS IN OFFICE
25
BILLS LED
28
COSPONSOR BREAKDOWNBIPARTISAN · 100%
DEM 2 REP 2 IND 0
ACTION TIMELINE
2 EVENTSMAY 8
Introduced in Senate
MAY 8
Read twice and referred to the Committee on Finance.
BILL INFO
TypeSenate Bill
NumberS 1702
Congress119th
StatusIn Committee
IntroducedMay 8, 2025
Last actionMay 8, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · FINANCE COMMITTEE · INTRODUCED MAY 8, 2025
Senate BillS 1702Health
Access to Prescription Digital Therapeutics Act of 2025
INTRODUCED MAY 8, 2025· LAST ACTION MAY 8, 2025
PASSAGE CHANCES
—%
READING
5 min
COSPONSORS
4
COMPLEXITY
Moderate
